{"id":15875,"date":"2021-12-14T13:00:01","date_gmt":"2021-12-14T13:00:01","guid":{"rendered":"https:\/\/incilab.az\/daun-paneli-testl%c9%99r-qrupu\/"},"modified":"2023-09-14T09:03:50","modified_gmt":"2023-09-14T09:03:50","slug":"down-panel-tests-group","status":"publish","type":"page","link":"https:\/\/incilab.az\/en\/down-panel-tests-group\/","title":{"rendered":"Down panel tests group"},"content":{"rendered":"<p>[vc_row][vc_column]<div class=\"bwl_acc_container\" id=\"accordion_2397621393\" data-search=\"\" data-placeholder=\"Search .....\" data-theme=\"theme-blue\" data-title_bg=\"#2C2C2C\" data-title_text_color=\"#FFFFFF\" data-nav_box_bg=\"#B8B831\" data-title_active_bg=\"#414141\" data-title_active_text_color=\"#F0F0F0\" data-nav_active_box_bg=\"#D0D051\" data-animate=\"slide\" data-rtl=\"\" data-msg_item_found=\" Item(s) Found !\" data-msg_no_result=\"Nothing Found !\" data-ctrl_btn=\"\" data-toggle=\"\" data-closeall=\"1\" data-item_opened=\"0\" data-nav_box=\"\" data-nav_icon=\"\" data-highlight_bg=\"#FFFF80\" data-highlight_color=\"#ff0000\" data-content_bg=\"\" data-content_text_color=\"\" data-content_link_color=\"\" data-content_link_hover_color=\"\"  data-pagination=\"\" data-limit=\"5\" data-nav_right=\"\" data-suggestion_box=\"\" data-sbox_title=\"Your KeyWords: \" data-sbox_keywords=\"faq, offer, exclusive, free, get\" data-query_string=\"0\"><section>\r\n                                        <h2 class=\"acc_title_bar\"><a href=\"#\"  style=\"font-size: 15px; !important\">ALFA-FETOPROTE\u0130N (AMN\u0130ON MAYES\u0130)<\/a><\/h2>\r\n                                        <div class=\"acc_container\" style=\"\">\r\n                                            <div class=\"block\">\r\n                                                <p><strong>N\u00fcmun\u0259 n\u00f6v\u00fc:<\/strong>\u00a0Amnion mayesi<\/p>\n<p><strong>N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n<p><strong>N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0200 \u03bcL<\/p>\n<p><strong>N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admu\u00adn\u0259 m\u00fcalic\u0259 h\u0259kimi t\u0259r\u0259find\u0259n g\u00f6\u00adt\u00fcr\u00fclm\u0259li v\u0259\u00a0 ikinci trimestr skrininq testi anket formas\u0131\u00a0 il\u0259 birg\u0259 g\u00f6nd\u0259\u00adril\u00adm\u0259lidir<\/p>\n<p><strong>\u0130\u015f prinsipi:\u00a0<\/strong>MEIA<\/p>\n<p><strong>Referens:\u00a0<\/strong>Laboratoriya il\u0259 \u0259laq\u0259 saxlamaq laz\u0131md\u0131r<\/p>\n<p><strong>\u0130stifad\u0259si:\u00a0<\/strong>Serumda AFP s\u0259viyy\u0259si y\u00fcks\u0259k \u00e7\u0131xan hamil\u0259l\u0259rd\u0259 d\u00f6ld\u0259ki nevroloji q\u00fcsurlar\u0131n diaqnostikas\u0131 \u00fc\u00e7\u00fcn istifad\u0259 olunur. Skrininq testdir, n\u0259tic\u0259nin neqativ \u00e7\u0131xmas\u0131 d\u00f6ld\u0259 nev\u00adroloji q\u00fcsurlar\u0131n olmas\u0131n\u0131 inkar et\u00admir. Pozitiv n\u0259tic\u0259l\u0259r asetilxo\u00adli\u00adnesteraza v\u0259 fetal hemoqlobinin t\u0259yi\u00adni il\u0259 t\u0259sdiql\u0259nm\u0259lidir. N\u0259z\u0259r\u0259 almaq laz\u0131md\u0131r ki, amnion mayesind\u0259 AFP-nin t\u0259yini zaman\u0131 fetal qan konta\u00adminasiyas\u0131 olarsa, yalan\u00e7\u0131 pozitivlik ehtimal\u0131 arta bil\u0259r. H\u0259m\u00e7inin bir s\u0131ra xo\u015fxass\u0259li hallarda da yalan\u00e7\u0131 y\u00fcks\u0259k n\u0259tic\u0259l\u0259r \u0259ld\u0259 oluna bil\u0259r<\/p>\n\r\n                                            <\/div>\r\n                                        <\/div>\r\n                                    <\/section><section>\r\n                                        <h2 class=\"acc_title_bar\"><a href=\"#\"  style=\"font-size: 15px; !important\">ALFA-FETOPROTE\u0130N (HAM\u0130L\u018fL\u0130K)<\/a><\/h2>\r\n                                        <div class=\"acc_container\" style=\"\">\r\n                                            <div class=\"block\">\r\n                                                <p><strong>N\u00fcmun\u0259 n\u00f6v\u00fc:<\/strong>\u00a0Serum<\/p>\n<p><strong>N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n<p><strong>N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0500 \u03bcL<\/p>\n<p><strong>N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admu\u00adn\u0259nin hamil\u0259liyin\u00a0 15-19-cu h\u0259f\u00adt\u0259\u00adl\u0259rind\u0259 al\u0131nmas\u0131 daha m\u0259qs\u0259d\u0259\u00aduy\u00ad\u011fundur. 15-21 h\u0259ft\u0259lik hamil\u0259likl\u0259r zaman\u0131 MoM d\u0259y\u0259ri ve\u00adril\u0259 bil\u0259r. Ris\u00adkin qiym\u0259tl\u0259n\u00addirilm\u0259si \u00fc\u00e7\u00fcn ikinci trimestr skrininq testi anket formas\u0131 doldurulmal\u0131d\u0131r<\/p>\n<p><strong>\u0130\u015f prinsipi:\u00a0<\/strong>MEIA<\/p>\n<p><strong>Referens:\u00a0<\/strong>N\u0259tic\u0259d\u0259 g\u00f6st\u0259rilir<\/p>\n<p><strong>\u0130stifad\u0259si:\u00a0<\/strong>D\u00f6ld\u0259ki nevroloji q\u00fcsur\u00adlar\u0131 t\u0259yin etm\u0259k\u00a0 \u00fc\u00e7\u00fcn prenatal skri\u00adninq testidir. B\u0259zi yana\u015fmalara g\u00f6r\u0259 I trimestr skrininq testind\u0259n sonra II trimestrd\u0259 yaln\u0131z AFP-nin m\u00fcayin\u0259si kifay\u0259tdir. Bu x\u0259st\u0259l\u0259rd\u0259 AFP MoM d\u0259y\u0259ri v\u0259 NTD \u00fc\u00e7\u00fcn hesablanan risk\u00a0 n\u0259tic\u0259d\u0259 bildirilir. H\u0259m\u00e7inin ya\u015f v\u0259 AFP s\u0259viyy\u0259sin\u0259 g\u00f6r\u0259 hesablanan\u00a0 Down\u00a0 sindromu\u00a0\u00a0 riski d\u0259 n\u0259tic\u0259d\u0259 yer al\u0131r<\/p>\n\r\n                                            <\/div>\r\n                                        <\/div>\r\n                                    <\/section><section>\r\n                                        <h2 class=\"acc_title_bar\"><a href=\"#\"  style=\"font-size: 15px; !important\">B\u0130R\u0130NC\u0130 TR\u0130MESTR SKR\u0130N\u0130NQ TEST\u0130<\/a><\/h2>\r\n                                        <div class=\"acc_container\" style=\"\">\r\n                                            <div class=\"block\">\r\n                                                <p><strong>Sinonim:\u00a0<\/strong>\u0130kili skrininq \u00a0testi<\/p>\n<p><strong>N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n<p><strong>N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n<p><strong>N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0500 \u03bcL<\/p>\n<p><strong>Test t\u0259rkibi:<\/strong>\u00a0S\u0259rb\u0259st \u03b2-hCG, PAPP-A v\u0259 USG il\u0259 \u0259ld\u0259 olunan nuchal translucency (NT) \u00f6l\u00e7\u00fclm\u0259si istifad\u0259 olunaraq trisomiya\u00a0 21-in (Daun) riskinin k\u0259miyy\u0259tc\u0259 t\u0259yini<\/p>\n<p><strong>N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>Ha\u00admil\u0259liyin 11-14-c\u00fc h\u0259ft\u0259l\u0259ri aras\u0131nda n\u00fcmun\u0259 al\u0131nmal\u0131d\u0131r. Birinci tremestr skrininq testind\u0259ki risk hesabla\u00adma\u00adlar\u0131nda istifad\u0259 olunacaq m\u0259lumat\u00adlar\u0131n d\u00fczg\u00fcnl\u00fcy\u00fc \u00e7ox \u0259h\u0259miyy\u0259tlidir. Riskin hesablamas\u0131 \u00fc\u00e7\u00fcn laz\u0131m olan m\u0259lumatlar a\u015fa\u011f\u0131dak\u0131lard\u0131r:<\/p>\n<ul>\n<li>Do\u011fum tarixi,<\/li>\n<li>Hamil\u0259 qald\u0131\u011f\u0131 vaxtdak\u0131 b\u0259d\u0259n \u00e7\u0259kisi,<\/li>\n<li>Son mensturasiya tarixi,<\/li>\n<li>Sonuncu ultras\u0259s m\u00fcayin\u0259sinin tarixi,<\/li>\n<li>Sonuncu ultras\u0259s m\u00fcayin\u0259sin\u0259 g\u00f6r\u0259 hamil\u0259liyin h\u0259ft\u0259si (CRL-y\u0259 g\u00f6r\u0259),<\/li>\n<li>Sonuncu ultras\u0259s m\u00fcayin\u0259sin\u0259 \u0259sa\u00ads\u0259n \u00f6l\u00e7\u00fcl\u0259n NT,<\/li>\n<li>D\u00f6l say\u0131,<\/li>\n<li>\u0130nsulin istifad\u0259 olunan \u015f\u0259k\u0259rli diabetin olmas\u0131,<\/li>\n<li>X\u0259st\u0259nin v\u0259 h\u0259kiminin ad\u0131 v\u0259 telefon n\u00f6mr\u0259si<\/li>\n<\/ul>\n<p><strong>\u0130\u015f prinsipi:<\/strong>\u00a0FIA<\/p>\n<p><strong>N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>H\u0259d\u00addind\u0259n art\u0131q hemoliz, lipemiya, sar\u0131l\u0131q v\u0259 m\u00fcnasib olmayan s\u0131naq \u015f\u00fc\u015f\u0259sin\u0259 al\u0131nm\u0131\u015f n\u00fcmun\u0259l\u0259r<\/p>\n<p><strong>Referens:<\/strong>\u00a0N\u0259tic\u0259d\u0259 bildirilir<\/p>\n<p><strong>\u0130stifad\u0259si:<\/strong>\u00a0Trisomiya 21 \u00fc\u00e7\u00fcn ha\u00admi\u00adl\u0259liyin erk\u0259n m\u0259rh\u0259l\u0259sind\u0259 (11 h\u0259ft\u0259-13 h\u0259ft\u0259 6 g\u00fcn) apar\u0131lan prenatal skrininq testdir. Anan\u0131n serumunda s\u0259rb\u0259st \u03b2-hCG v\u0259 PAPP-A konsen\u00adtrasiyas\u0131 il\u0259 y\u00fcks\u0259k h\u0259ssasl\u0131ql\u0131 USM istifad\u0259 olunaraq \u00f6l\u00e7\u00fcl\u0259n nuchal trans\u00adlucensy (NT-\u0259ns\u0259 \u015f\u0259ffafl\u0131\u011f\u0131) n\u0259tic\u0259si, hamil\u0259liyin h\u0259ft\u0259si, anan\u0131n ya\u015f\u0131 v\u0259 dig\u0259r m\u0259lumatlarla kombi\u00adna\u00adsiya edil\u0259r\u0259k k\u0259miyy\u0259tc\u0259 risk qiy\u00adm\u0259tl\u0259n\u00addiril\u00adm\u0259si apar\u0131l\u0131r. Bu, skrininq testi oldu\u011fundan, normal n\u0259tic\u0259l\u0259r d\u00f6l\u00fcn h\u0259r hans\u0131 bir q\u00fcsur da\u015f\u0131\u00adma\u00add\u0131\u011f\u0131n\u0131 birm\u0259nal\u0131 t\u0259sdiq etmir.\u00a0 Eyni zamanda anormal test n\u0259tic\u0259l\u0259rinin d\u0259 d\u0259qiql\u0259\u015fdirilm\u0259si \u00fc\u00e7\u00fcn genetik m\u00fcayin\u0259l\u0259r\u0259 ehtiyac vard\u0131r<\/p>\n\r\n                                            <\/div>\r\n                                        <\/div>\r\n                                    <\/section><section>\r\n                                        <h2 class=\"acc_title_bar\"><a href=\"#\"  style=\"font-size: 15px; !important\">\u0130K\u0130NC\u0130 TR\u0130MESTER SKR\u0130N\u0130NQ TEST\u0130 (\u00dc\u00c7L\u00dc SKR\u0130N\u0130NQ TEST\u0130)<\/a><\/h2>\r\n                                        <div class=\"acc_container\" style=\"\">\r\n                                            <div class=\"block\">\r\n                                                <p><strong>Sinonim:<\/strong>\u00a0Triple test<\/p>\n<p><strong>N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n<p><strong>N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n<p><strong>N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0500 \u03bcL<\/p>\n<p><strong>Testin t\u0259rkibi:<\/strong>\u00a0AFP, hCG, uE<sub>3<\/sub>\u00a0t\u0259\u00adyini v\u0259 kantitativ risk m\u00fc\u0259yy\u0259n etm\u0259<\/p>\n<p><strong>N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:<\/strong>\u00a0N\u00fc\u00admu\u00adn\u0259 hamil\u0259liyin 14-24 c\u00fc h\u0259ft\u0259\u00adl\u0259rind\u0259 al\u0131nmal\u0131d\u0131r. \u00dc\u00e7l\u00fc skrininq tes\u00adtind\u0259ki risk hesablanmalar\u0131nda is\u00adti\u00adfad\u0259 olunacaq m\u0259lumatlar\u0131n do\u011f\u00adru\u00adlu\u011fu \u00e7ox \u0259h\u0259miyy\u0259tlidir. Risk hesab\u00adlamas\u0131 \u00fc\u00e7\u00fcn laz\u0131m olam m\u0259lumatlar a\u015fa\u011f\u0131dak\u0131lard\u0131r:<\/p>\n<ul>\n<li>Do\u011fum tarixi,<\/li>\n<li>Hamil\u0259 qald\u0131\u011f\u0131 vaxtdak\u0131 \u00e7\u0259kisi,<\/li>\n<li>Son menstruasiya tarixi,<\/li>\n<li>\u018fn son olunan USM-in tarixi,<\/li>\n<li>\u018fn son olunan USM-\u0259 g\u00f6r\u0259 ha\u00admil\u0259liyin h\u0259ft\u0259si (CRL-y\u0259 g\u00f6r\u0259 ),<\/li>\n<li>\u018fn son olunan USM-d\u0259 \u00f6l\u00e7\u00fcl\u0259n NT,<\/li>\n<li>D\u00f6l say\u0131,<\/li>\n<li>\u0130nsulin istifad\u0259 olunan \u015f\u0259k\u0259rli diabetin olmas\u0131,<\/li>\n<li>Ail\u0259d\u0259 NTD anamnezi<\/li>\n<li>X\u0259st\u0259nin v\u0259 h\u0259kiminin ad\u0131 v\u0259 te\u00adlefon n\u00f6mr\u0259si<\/li>\n<\/ul>\n<p><strong>\u0130\u015f prinsipi:<\/strong>\u00a0MEIA + FIA<\/p>\n<p><strong>N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0G\u00f6st\u0259rilmi\u015f hamil\u0259lik h\u0259ft\u0259l\u0259rinin xaricind\u0259ki v\u0259 ya uy\u011fun olmayan s\u0131naq \u015f\u00fc\u015f\u0259sin\u0259 al\u0131nm\u0131\u015f n\u00fcmun\u0259l\u0259r<\/p>\n<p><strong>Referens:<\/strong>\u00a0NTD \u00fc\u00e7\u00fcn 1\/1000, Tri\u00adsomiya 21 \u00fc\u00e7\u00fcn 1\/270 v\u0259 Trisomiya 18 \u00fc\u00e7\u00fcn 1\/100-d\u0259n y\u00fcks\u0259k n\u0259tic\u0259l\u0259r riskli kimi q\u0259bul edilir<\/p>\n<p><strong>\u0130stifad\u0259si:\u00a0<\/strong>D\u00f6ld\u0259ki nevroloji de\u00adfekt\u00adl\u0259r, trisomiya 21 v\u0259 trisomiya 18 \u00fc\u00e7\u00fcn prenatal skrininq testdir. D\u00f6l\u00add\u0259ki nevroloji defektl\u0259r \u00fc\u00e7\u00fcn AFP, trisomiya 21 v\u0259 trisomiya 18 \u00fc\u00e7\u00fcn AFP, uE<sub>3<\/sub>\u00a0v\u0259 hCG-nin hamil\u0259lik h\u0259ft\u0259sin\u0259 g\u00f6r\u0259 n\u0259tic\u0259l\u0259ri, anan\u0131n ya\u015f\u0131 il\u0259 kombinasiya edil\u0259r\u0259k k\u0259miyy\u0259tc\u0259 risk t\u0259yini apar\u0131la bil\u0259r. Bunun skri\u00adninq test oldu\u011fu unudulma\u00admal\u0131d\u0131r. Normal n\u0259tic\u0259l\u0259r d\u00f6l\u00fcn h\u0259r hans\u0131 de\u00adfekt da\u015f\u0131mad\u0131\u011f\u0131 m\u0259nas\u0131na g\u0259lm\u0259diyi kimi, anormal n\u0259tic\u0259l\u0259rin d\u0259 d\u0259\u00adqiq\u00adl\u0259\u015fdirilm\u0259si \u00fc\u00e7\u00fcn genetik m\u00fca\u00adyi\u00adn\u0259l\u0259r\u0259 ehtiyac vard\u0131r. M\u00fcayin\u0259 \u00fc\u00e7\u00fcn 16-18-ci hamil\u0259lik h\u0259ft\u0259si ideald\u0131r, lakin 14-24-c\u00fc h\u0259ft\u0259l\u0259rd\u0259 m\u00fcayin\u0259 apar\u0131la bil\u0259r<\/p>\n\r\n                                            <\/div>\r\n                                        <\/div>\r\n                                    <\/section><section>\r\n                                        <h2 class=\"acc_title_bar\"><a href=\"#\"  style=\"font-size: 15px; !important\">TR\u0130PLE TEST (\u00dc\u00c7L\u00dc SKR\u0130N\u0130NQ TEST\u0130)<\/a><\/h2>\r\n                                        <div class=\"acc_container\" style=\"\">\r\n                                            <div class=\"block\">\r\n                                                <p><strong>Sinonim:<\/strong>\u00a0Triple test<\/p>\n<p><strong>N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n<p><strong>N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n<p><strong>N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0500 \u03bcL<\/p>\n<p><strong>Testin t\u0259rkibi:<\/strong>\u00a0AFP, hCG, uE<sub>3<\/sub>\u00a0t\u0259\u00adyini v\u0259 kantitativ risk m\u00fc\u0259yy\u0259n etm\u0259<\/p>\n<p><strong>N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:<\/strong>\u00a0N\u00fc\u00admu\u00adn\u0259 hamil\u0259liyin 14-24 c\u00fc h\u0259ft\u0259\u00adl\u0259rind\u0259 al\u0131nmal\u0131d\u0131r. \u00dc\u00e7l\u00fc skrininq tes\u00adtind\u0259ki risk hesablanmalar\u0131nda is\u00adti\u00adfad\u0259 olunacaq m\u0259lumatlar\u0131n do\u011f\u00adru\u00adlu\u011fu \u00e7ox \u0259h\u0259miyy\u0259tlidir. Risk hesab\u00adlamas\u0131 \u00fc\u00e7\u00fcn laz\u0131m olam m\u0259lumatlar a\u015fa\u011f\u0131dak\u0131lard\u0131r:<\/p>\n<ul>\n<li>Do\u011fum tarixi,<\/li>\n<li>Hamil\u0259 qald\u0131\u011f\u0131 vaxtdak\u0131 \u00e7\u0259kisi,<\/li>\n<li>Son menstruasiya tarixi,<\/li>\n<li>\u018fn son olunan USM-in tarixi,<\/li>\n<li>\u018fn son olunan USM-\u0259 g\u00f6r\u0259 ha\u00admil\u0259liyin h\u0259ft\u0259si (CRL-y\u0259 g\u00f6r\u0259 ),<\/li>\n<li>\u018fn son olunan USM-d\u0259 \u00f6l\u00e7\u00fcl\u0259n NT,<\/li>\n<li>D\u00f6l say\u0131,<\/li>\n<li>\u0130nsulin istifad\u0259 olunan \u015f\u0259k\u0259rli diabetin olmas\u0131,<\/li>\n<li>Ail\u0259d\u0259 NTD anamnezi<\/li>\n<li>X\u0259st\u0259nin v\u0259 h\u0259kiminin ad\u0131 v\u0259 te\u00adlefon n\u00f6mr\u0259si<\/li>\n<\/ul>\n<p><strong>\u0130\u015f prinsipi:<\/strong>\u00a0MEIA + FIA<\/p>\n<p><strong>N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0G\u00f6st\u0259rilmi\u015f hamil\u0259lik h\u0259ft\u0259l\u0259rinin xaricind\u0259ki v\u0259 ya uy\u011fun olmayan s\u0131naq \u015f\u00fc\u015f\u0259sin\u0259 al\u0131nm\u0131\u015f n\u00fcmun\u0259l\u0259r<\/p>\n<p><strong>Referens:<\/strong>\u00a0NTD \u00fc\u00e7\u00fcn 1\/1000, Tri\u00adsomiya 21 \u00fc\u00e7\u00fcn 1\/270 v\u0259 Trisomiya 18 \u00fc\u00e7\u00fcn 1\/100-d\u0259n y\u00fcks\u0259k n\u0259tic\u0259l\u0259r riskli kimi q\u0259bul edilir<\/p>\n<p><strong>\u0130stifad\u0259si:\u00a0<\/strong>D\u00f6ld\u0259ki nevroloji de\u00adfekt\u00adl\u0259r, trisomiya 21 v\u0259 trisomiya 18 \u00fc\u00e7\u00fcn prenatal skrininq testdir. D\u00f6l\u00add\u0259ki nevroloji defektl\u0259r \u00fc\u00e7\u00fcn AFP, trisomiya 21 v\u0259 trisomiya 18 \u00fc\u00e7\u00fcn AFP, uE<sub>3<\/sub>\u00a0v\u0259 hCG-nin hamil\u0259lik h\u0259ft\u0259sin\u0259 g\u00f6r\u0259 n\u0259tic\u0259l\u0259ri, anan\u0131n ya\u015f\u0131 il\u0259 kombinasiya edil\u0259r\u0259k k\u0259miyy\u0259tc\u0259 risk t\u0259yini apar\u0131la bil\u0259r. Bunun skri\u00adninq test oldu\u011fu unudulma\u00admal\u0131d\u0131r. Normal n\u0259tic\u0259l\u0259r d\u00f6l\u00fcn h\u0259r hans\u0131 de\u00adfekt da\u015f\u0131mad\u0131\u011f\u0131 m\u0259nas\u0131na g\u0259lm\u0259diyi kimi, anormal n\u0259tic\u0259l\u0259rin d\u0259 d\u0259\u00adqiq\u00adl\u0259\u015fdirilm\u0259si \u00fc\u00e7\u00fcn genetik m\u00fca\u00adyi\u00adn\u0259l\u0259r\u0259 ehtiyac vard\u0131r. M\u00fcayin\u0259 \u00fc\u00e7\u00fcn 16-18-ci hamil\u0259lik h\u0259ft\u0259si ideald\u0131r, lakin 14-24-c\u00fc h\u0259ft\u0259l\u0259rd\u0259 m\u00fcayin\u0259 apar\u0131la bil\u0259r<\/p>\n\r\n                                            <\/div>\r\n                                        <\/div>\r\n                                    <\/section><section>\r\n                                        <h2 class=\"acc_title_bar\"><a href=\"#\"  style=\"font-size: 15px; !important\">\u00dc\u00c7L\u00dc SKR\u0130N\u0130NQ TEST\u0130<\/a><\/h2>\r\n                                        <div class=\"acc_container\" style=\"\">\r\n                                            <div class=\"block\">\r\n                                                <p><strong>Sinonim:<\/strong>\u00a0Triple test<\/p>\n<p><strong>N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n<p><strong>N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n<p><strong>N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0500 \u03bcL<\/p>\n<p><strong>Testin t\u0259rkibi:<\/strong>\u00a0AFP, hCG, uE<sub>3<\/sub>\u00a0t\u0259\u00adyini v\u0259 kantitativ risk m\u00fc\u0259yy\u0259n etm\u0259<\/p>\n<p><strong>N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:<\/strong>\u00a0N\u00fc\u00admu\u00adn\u0259 hamil\u0259liyin 14-24 c\u00fc h\u0259ft\u0259\u00adl\u0259rind\u0259 al\u0131nmal\u0131d\u0131r. \u00dc\u00e7l\u00fc skrininq tes\u00adtind\u0259ki risk hesablanmalar\u0131nda is\u00adti\u00adfad\u0259 olunacaq m\u0259lumatlar\u0131n do\u011f\u00adru\u00adlu\u011fu \u00e7ox \u0259h\u0259miyy\u0259tlidir. Risk hesab\u00adlamas\u0131 \u00fc\u00e7\u00fcn laz\u0131m olam m\u0259lumatlar a\u015fa\u011f\u0131dak\u0131lard\u0131r:<\/p>\n<ul>\n<li>Do\u011fum tarixi,<\/li>\n<li>Hamil\u0259 qald\u0131\u011f\u0131 vaxtdak\u0131 \u00e7\u0259kisi,<\/li>\n<li>Son menstruasiya tarixi,<\/li>\n<li>\u018fn son olunan USM-in tarixi,<\/li>\n<li>\u018fn son olunan USM-\u0259 g\u00f6r\u0259 ha\u00admil\u0259liyin h\u0259ft\u0259si (CRL-y\u0259 g\u00f6r\u0259 ),<\/li>\n<li>\u018fn son olunan USM-d\u0259 \u00f6l\u00e7\u00fcl\u0259n NT,<\/li>\n<li>D\u00f6l say\u0131,<\/li>\n<li>\u0130nsulin istifad\u0259 olunan \u015f\u0259k\u0259rli diabetin olmas\u0131,<\/li>\n<li>Ail\u0259d\u0259 NTD anamnezi<\/li>\n<li>X\u0259st\u0259nin v\u0259 h\u0259kiminin ad\u0131 v\u0259 te\u00adlefon n\u00f6mr\u0259si<\/li>\n<\/ul>\n<p><strong>\u0130\u015f prinsipi:<\/strong>\u00a0MEIA + FIA<\/p>\n<p><strong>N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0G\u00f6st\u0259rilmi\u015f hamil\u0259lik h\u0259ft\u0259l\u0259rinin xaricind\u0259ki v\u0259 ya uy\u011fun olmayan s\u0131naq \u015f\u00fc\u015f\u0259sin\u0259 al\u0131nm\u0131\u015f n\u00fcmun\u0259l\u0259r<\/p>\n<p><strong>Referens:<\/strong>\u00a0NTD \u00fc\u00e7\u00fcn 1\/1000, Tri\u00adsomiya 21 \u00fc\u00e7\u00fcn 1\/270 v\u0259 Trisomiya 18 \u00fc\u00e7\u00fcn 1\/100-d\u0259n y\u00fcks\u0259k n\u0259tic\u0259l\u0259r riskli kimi q\u0259bul edilir<\/p>\n<p><strong>\u0130stifad\u0259si:\u00a0<\/strong>D\u00f6ld\u0259ki nevroloji de\u00adfekt\u00adl\u0259r, trisomiya 21 v\u0259 trisomiya 18 \u00fc\u00e7\u00fcn prenatal skrininq testdir. D\u00f6l\u00add\u0259ki nevroloji defektl\u0259r \u00fc\u00e7\u00fcn AFP, trisomiya 21 v\u0259 trisomiya 18 \u00fc\u00e7\u00fcn AFP, uE<sub>3<\/sub>\u00a0v\u0259 hCG-nin hamil\u0259lik h\u0259ft\u0259sin\u0259 g\u00f6r\u0259 n\u0259tic\u0259l\u0259ri, anan\u0131n ya\u015f\u0131 il\u0259 kombinasiya edil\u0259r\u0259k k\u0259miyy\u0259tc\u0259 risk t\u0259yini apar\u0131la bil\u0259r. Bunun skri\u00adninq test oldu\u011fu unudulma\u00admal\u0131d\u0131r. Normal n\u0259tic\u0259l\u0259r d\u00f6l\u00fcn h\u0259r hans\u0131 de\u00adfekt da\u015f\u0131mad\u0131\u011f\u0131 m\u0259nas\u0131na g\u0259lm\u0259diyi kimi, anormal n\u0259tic\u0259l\u0259rin d\u0259 d\u0259\u00adqiq\u00adl\u0259\u015fdirilm\u0259si \u00fc\u00e7\u00fcn genetik m\u00fca\u00adyi\u00adn\u0259l\u0259r\u0259 ehtiyac vard\u0131r. M\u00fcayin\u0259 \u00fc\u00e7\u00fcn 16-18-ci hamil\u0259lik h\u0259ft\u0259si ideald\u0131r, lakin 14-24-c\u00fc h\u0259ft\u0259l\u0259rd\u0259 m\u00fcayin\u0259 apar\u0131la bil\u0259r<\/p>\n\r\n                                            <\/div>\r\n                                        <\/div>\r\n                                    <\/section><\/div>[\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-15875","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages\/15875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/comments?post=15875"}],"version-history":[{"count":2,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages\/15875\/revisions"}],"predecessor-version":[{"id":15914,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages\/15875\/revisions\/15914"}],"wp:attachment":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/media?parent=15875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}